Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge

Vaccine

Volumn 27, Issue 21, 2009, Pages 2741-2745

  Shang, Limin ^a   Liu, Quan ^a   Liu, Wensen ^a   Men, Jingtao ^a   Gao, Shengyan ^a   Jiang, Li ^a   Wang, Ze ^a   Zhai, Yujia ^a   Jin, Hongtao ^a   Lian, Hai ^a   Chen, Chen ^a   Xia, Zhiping ^a   Yuan, Ziguo ^b   Zhu, Xing Quan ^b  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

DNA vaccine; Mice; Prime boost regime; Pseudorabies virus; TgSAG1; Toxoplasma gondii

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; PSEUDORABIES VACCINE; TOXOPLASMA GONDII VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PARASITE TRANSMISSION; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES; ANTIGENS, PROTOZOAN; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; HERPESVIRUS 1, SUID; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SPLEEN; TOXOPLASMA; TOXOPLASMOSIS; VACCINES, DNA;

EID: 64449087926     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.013     Document Type: Article

References (28)

1. Tenter A.M., Heckeroth A.R., and Weiss L.M. Toxoplasma gondii: from animals to humans. Int J Parasitol 30 12-13 (2000) 1217-1258
2. Kijlstra A., and Jongert E. Toxoplasma-safe meat: close to reality?. Trends Parasitol 25 1 (2009) 18-22
3. Mohamed R.M., Aosai F., Chen M., Mun H.S., Norose K., Belal U.S., et al. Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes. Vaccine 21 21-22 (2003) 2852-2861
4. Couper K.N., Nielsen H.V., Petersen E., Roberts F., Roberts C.W., and Alexander J. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine 21 21-22 (2003) 2813-2820
5. Fachado A., Rodriguez A., Angel S.O., Pinto D.C., Vila I., Acosta A., et al. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 21 13-14 (2003) 1327-1335
6. Scorza T., D'Souza S., Laloup M., Dewit J., De Braekeleer J., Verschueren H., et al. A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection. Infect Immun 71 1 (2003) 309-316
7. Doria-Rose N.A., and Haigwood N.L. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 31 3 (2003) 207-216
8. Dunachie S.J., and Hill A.V. Prime-boost strategies for malaria vaccine development. J Exp Biol 206 Part 21 (2003) 3771-3779
9. Tewary P., Jain M., Sahani M.H., Saxena S., and Madhubala R. A heterologous prime-boost vaccination regimen using ORFF DNA and recombinant ORFF protein confers protective immunity against experimental visceral leishmaniasis. J Infect Dis 191 12 (2005) 2130-2137
10. Dondji B., Perez-Jimenez E., Goldsmith-Pestana K., Esteban M., and McMahon-Pratt D. Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis. Infect Immun 73 8 (2005) 5286-5289
11. Burg J.L., Perelman D., Kasper L.H., Ware P.L., and Boothroyd J.C. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol 141 10 (1988) 3584-3591
12. Angus C.W., Klivington-Evans D., Dubey J.P., and Kovacs J.A. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 181 1 (2000) 317-324
13. Liu Q., Gao S., Jiang L., Shang L., Men J., Wang Z., et al. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Microbes Infect 10 12-13 (2008) 1355-1362
14. Desolme B., Mevelec M.N., Buzoni-Gatel D., and Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18 23 (2000) 2512-2521
15. Miller C.M., Boulter N.R., Ikin R.J., and Smith N.C. The immunobiology of the innate response to Toxoplasma gondii. Int J Parasitol 39 1 (2009) 23-39
16. Gazzinelli R.T., Hakim F.T., Hieny S., Shearer G.M., and Sher A. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146 1 (1991) 286-292
17. Khan I.A., Matsuura T., and Kasper L.H. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. J Immunol 161 6 (1998) 2994-3000
18. Yang C.D., Chang G.N., and Chao D. Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2. Parasitol Res 92 1 (2004) 58-64
19. Petersen E., Nielsen H.V., Christiansen L., and Spenter J. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine 16 13 (1998) 1283-1289
20. Darcy F., Maes P., Gras-Masse H., Auriault C., Bossus M., Deslee D., et al. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. J Immunol 149 11 (1992) 3636-3641
21. Flori P., Tardy L., Jacquet A., Bellete B., Hafid J., Raberin H., et al. Effect of rSAG-1(P30) immunisation on the circulating and tissue parasites in guinea pigs as determined by quantitative PCR. Parasitol Res 98 6 (2006) 511-518
22. Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., and Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun 67 12 (1999) 6358-6363
23. Brandsma J.L. DNA vaccine design. Methods Mol Med 127 (2006) 3-10
24. Miller R., Wen X., Dunford B., Wang X., and Suzuki Y. Cytokine production of CD8+ immune T cells but not of CD4+ T cells from Toxoplasma gondii-infected mice is polarized to a type 1 response following stimulation with tachyzoite-infected macrophages. J Interferon Cytokine Res 26 11 (2006) 787-792
25. Denkers E.Y. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes Infect 1 9 (1999) 699-708
26. Thomsen D.R., Marotti K.R., Palermo D.P., and Post L.E. Pseudorabies virus as a live virus vector for expression of foreign genes. Gene 57 2-3 (1987) 261-265
27. Qiu H.J., Tian Z.J., Tong G.Z., Zhou Y.J., Ni J.Q., Luo Y.Z., et al. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet Immunol Immunopathol 106 3-4 (2005) 309-319
28. van Zijl M., Wensvoort G., de Kluyver E., Hulst M., van der Gulden H., Gielkens A., et al. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol 65 5 (1991) 2761-2765